Below are some of the details of Moxifloxacin (generic)
 

Moxifloxacin is a third generation synthetic fluoroquinolone chemotherapeutic agent developed by Bayer AG (initially called BAY 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox and Avelon for oral treatment. In most countries the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand name Vigamox for the treatment of conjunctivitis (pink eye).